C5a alters blood-brain barrier integrity in experimental lupus

Alexander Jacob, Bradley Hack, Eddie Chiang, Joe GN Garcia, Richard J. Quigg, Jessy J. Alexander

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The blood-brain barrier (BBB) is a crucial anatomic location in the brain. Its dysfunction complicates many neurodegenerative diseases, from acute conditions, such as sepsis, to chronic diseases, such as systemic lupus erythematosus (SLE). Several studies suggest an altered BBB in lupus, but the underlying mechanism remains unknown. In the current study, we observed a definite loss of BBB integrity in MRL/MpJ-Tnfrsf6lpr (MRL/lpr) lupus mice by IgG infiltration into brain parenchyma. In line with this result, we examined the role of complement activation, a key event in this setting, in maintenance of BBB integrity. Complement activation generates C5a, a molecule with multiple functions. Because the expression of the C5a receptor (C5aR) is significantly increased in brain endothelial cells treated with lupus serum, the study focused on the role of C5a signaling through its G-protein-coupled receptor C5aR in brain endothelial cells, in a lupus setting. Reactive oxygen species production increased significantly in endothelial cells, in both primary cells and the bEnd3 cell line treated with lupus serum from MRL/lpr mice, compared with those treated with control serum from MRL+/+ mice. In addition, increased permeability monitored by changes in transendothelial electrical resistance, cytoskeletal remodeling caused by actin fiber rearrangement, and increased iNOS mRNA expression were observed in bEnd3 cells. These disruptive effects were alleviated by pretreating cells with a C5a receptor antagonist (C5aRant) or a C5a antibody. Furthermore, the structural integrity of the vasculature in MRL/lpr brain was maintained by C5aR inhibition. These results demonstrate the regulation of BBB integrity by the complement system in a neuroinflammatory setting. For the first time, a novel role of C5a in the maintenance of BBB integrity is identified and the potential of C5a/C5aR blockade highlighted as a promising therapeutic strategy in SLE and other neurodegenerative diseases.

Original languageEnglish (US)
Pages (from-to)1682-1688
Number of pages7
JournalFASEB Journal
Volume24
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Anaphylatoxin C5a Receptor
Blood-Brain Barrier
Brain
Endothelial cells
Neurodegenerative diseases
Endothelial Cells
Complement Activation
Neurodegenerative Diseases
Systemic Lupus Erythematosus
Serum
Chemical activation
Maintenance
Acoustic impedance
Structural integrity
G-Protein-Coupled Receptors
Electric Impedance
Infiltration
Actins
Permeability
Reactive Oxygen Species

Keywords

  • Complement system
  • Endothelium
  • Neurodegeneration
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Jacob, A., Hack, B., Chiang, E., Garcia, J. GN., Quigg, R. J., & Alexander, J. J. (2010). C5a alters blood-brain barrier integrity in experimental lupus. FASEB Journal, 24(6), 1682-1688. https://doi.org/10.1096/fj.09-138834

C5a alters blood-brain barrier integrity in experimental lupus. / Jacob, Alexander; Hack, Bradley; Chiang, Eddie; Garcia, Joe GN; Quigg, Richard J.; Alexander, Jessy J.

In: FASEB Journal, Vol. 24, No. 6, 06.2010, p. 1682-1688.

Research output: Contribution to journalArticle

Jacob, A, Hack, B, Chiang, E, Garcia, JGN, Quigg, RJ & Alexander, JJ 2010, 'C5a alters blood-brain barrier integrity in experimental lupus', FASEB Journal, vol. 24, no. 6, pp. 1682-1688. https://doi.org/10.1096/fj.09-138834
Jacob, Alexander ; Hack, Bradley ; Chiang, Eddie ; Garcia, Joe GN ; Quigg, Richard J. ; Alexander, Jessy J. / C5a alters blood-brain barrier integrity in experimental lupus. In: FASEB Journal. 2010 ; Vol. 24, No. 6. pp. 1682-1688.
@article{8dbe389778f84d239fc0f0c8eea17700,
title = "C5a alters blood-brain barrier integrity in experimental lupus",
abstract = "The blood-brain barrier (BBB) is a crucial anatomic location in the brain. Its dysfunction complicates many neurodegenerative diseases, from acute conditions, such as sepsis, to chronic diseases, such as systemic lupus erythematosus (SLE). Several studies suggest an altered BBB in lupus, but the underlying mechanism remains unknown. In the current study, we observed a definite loss of BBB integrity in MRL/MpJ-Tnfrsf6lpr (MRL/lpr) lupus mice by IgG infiltration into brain parenchyma. In line with this result, we examined the role of complement activation, a key event in this setting, in maintenance of BBB integrity. Complement activation generates C5a, a molecule with multiple functions. Because the expression of the C5a receptor (C5aR) is significantly increased in brain endothelial cells treated with lupus serum, the study focused on the role of C5a signaling through its G-protein-coupled receptor C5aR in brain endothelial cells, in a lupus setting. Reactive oxygen species production increased significantly in endothelial cells, in both primary cells and the bEnd3 cell line treated with lupus serum from MRL/lpr mice, compared with those treated with control serum from MRL+/+ mice. In addition, increased permeability monitored by changes in transendothelial electrical resistance, cytoskeletal remodeling caused by actin fiber rearrangement, and increased iNOS mRNA expression were observed in bEnd3 cells. These disruptive effects were alleviated by pretreating cells with a C5a receptor antagonist (C5aRant) or a C5a antibody. Furthermore, the structural integrity of the vasculature in MRL/lpr brain was maintained by C5aR inhibition. These results demonstrate the regulation of BBB integrity by the complement system in a neuroinflammatory setting. For the first time, a novel role of C5a in the maintenance of BBB integrity is identified and the potential of C5a/C5aR blockade highlighted as a promising therapeutic strategy in SLE and other neurodegenerative diseases.",
keywords = "Complement system, Endothelium, Neurodegeneration, Systemic lupus erythematosus",
author = "Alexander Jacob and Bradley Hack and Eddie Chiang and Garcia, {Joe GN} and Quigg, {Richard J.} and Alexander, {Jessy J.}",
year = "2010",
month = "6",
doi = "10.1096/fj.09-138834",
language = "English (US)",
volume = "24",
pages = "1682--1688",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - C5a alters blood-brain barrier integrity in experimental lupus

AU - Jacob, Alexander

AU - Hack, Bradley

AU - Chiang, Eddie

AU - Garcia, Joe GN

AU - Quigg, Richard J.

AU - Alexander, Jessy J.

PY - 2010/6

Y1 - 2010/6

N2 - The blood-brain barrier (BBB) is a crucial anatomic location in the brain. Its dysfunction complicates many neurodegenerative diseases, from acute conditions, such as sepsis, to chronic diseases, such as systemic lupus erythematosus (SLE). Several studies suggest an altered BBB in lupus, but the underlying mechanism remains unknown. In the current study, we observed a definite loss of BBB integrity in MRL/MpJ-Tnfrsf6lpr (MRL/lpr) lupus mice by IgG infiltration into brain parenchyma. In line with this result, we examined the role of complement activation, a key event in this setting, in maintenance of BBB integrity. Complement activation generates C5a, a molecule with multiple functions. Because the expression of the C5a receptor (C5aR) is significantly increased in brain endothelial cells treated with lupus serum, the study focused on the role of C5a signaling through its G-protein-coupled receptor C5aR in brain endothelial cells, in a lupus setting. Reactive oxygen species production increased significantly in endothelial cells, in both primary cells and the bEnd3 cell line treated with lupus serum from MRL/lpr mice, compared with those treated with control serum from MRL+/+ mice. In addition, increased permeability monitored by changes in transendothelial electrical resistance, cytoskeletal remodeling caused by actin fiber rearrangement, and increased iNOS mRNA expression were observed in bEnd3 cells. These disruptive effects were alleviated by pretreating cells with a C5a receptor antagonist (C5aRant) or a C5a antibody. Furthermore, the structural integrity of the vasculature in MRL/lpr brain was maintained by C5aR inhibition. These results demonstrate the regulation of BBB integrity by the complement system in a neuroinflammatory setting. For the first time, a novel role of C5a in the maintenance of BBB integrity is identified and the potential of C5a/C5aR blockade highlighted as a promising therapeutic strategy in SLE and other neurodegenerative diseases.

AB - The blood-brain barrier (BBB) is a crucial anatomic location in the brain. Its dysfunction complicates many neurodegenerative diseases, from acute conditions, such as sepsis, to chronic diseases, such as systemic lupus erythematosus (SLE). Several studies suggest an altered BBB in lupus, but the underlying mechanism remains unknown. In the current study, we observed a definite loss of BBB integrity in MRL/MpJ-Tnfrsf6lpr (MRL/lpr) lupus mice by IgG infiltration into brain parenchyma. In line with this result, we examined the role of complement activation, a key event in this setting, in maintenance of BBB integrity. Complement activation generates C5a, a molecule with multiple functions. Because the expression of the C5a receptor (C5aR) is significantly increased in brain endothelial cells treated with lupus serum, the study focused on the role of C5a signaling through its G-protein-coupled receptor C5aR in brain endothelial cells, in a lupus setting. Reactive oxygen species production increased significantly in endothelial cells, in both primary cells and the bEnd3 cell line treated with lupus serum from MRL/lpr mice, compared with those treated with control serum from MRL+/+ mice. In addition, increased permeability monitored by changes in transendothelial electrical resistance, cytoskeletal remodeling caused by actin fiber rearrangement, and increased iNOS mRNA expression were observed in bEnd3 cells. These disruptive effects were alleviated by pretreating cells with a C5a receptor antagonist (C5aRant) or a C5a antibody. Furthermore, the structural integrity of the vasculature in MRL/lpr brain was maintained by C5aR inhibition. These results demonstrate the regulation of BBB integrity by the complement system in a neuroinflammatory setting. For the first time, a novel role of C5a in the maintenance of BBB integrity is identified and the potential of C5a/C5aR blockade highlighted as a promising therapeutic strategy in SLE and other neurodegenerative diseases.

KW - Complement system

KW - Endothelium

KW - Neurodegeneration

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=77953522365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953522365&partnerID=8YFLogxK

U2 - 10.1096/fj.09-138834

DO - 10.1096/fj.09-138834

M3 - Article

C2 - 20065106

AN - SCOPUS:77953522365

VL - 24

SP - 1682

EP - 1688

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 6

ER -